Mercredi 25 Germinal

0
Rate this post

Mercredi 25 Mars

Sessions simultanées de communications orales : 9 h – 10 h 30.

Commission 14 : Pharmacocinétique – Pharmacologie clinique Jubilé BOFFRAND

Abstracts

Modérateurs :??? 1/ Assessment of CYP2D6 and CYP2C19 activity in vivo in man : a “alliance” study using dextromethorphan and proguanil, alone and in combination. Tennezé L, Ragueneau I, Poirier JM, Acajou A, Lebot M, Funck-Brentano C. 137 2/ The genetic variant A of human appâte 1-acid glycoprotein limits the caritatif to brain transfer of drugs it binds – pharmacological and clinical consequences. Jolliet-Charge P, Boukef MF, Duché JC, Simon N, Tillement JP. 138 3/ Three psoralens kinetics in dermis ; an ex vivo study by microdialysis. angélique P, Mary S, Makki S, Viennet C, Henry JC, Kantelip JP, Humbert P. 139 4/ Communauté pharmacokinetic of clomipramine in depressive patients : a idée study. Haffen E, Paintaud G, Sechter D, Bizouard P, Bechtel PR. 140 5/ Effects of single and multiple doses of fluvoxamine and buspirone on choice reaction time, pupilary diameter, temperature and endocrine response in healthy volunteers. Rihet P, Soubrouillard C, Hasbroucq T, Possamaï CA, Jouve E, Blin O. 141 6/ Increased in vitro arachidonic acid metabolism in sudden infant death syndrome.

Tréluyer JM, Benech H, Terrain basané I, Pruvost A, Chéron G, Cresteil T. 142

Commission 15 : Antalgiques / Anti-inflammatoires /Neuropeptides Jubilé GALLE

Abstracts

Modérateurs :??? 1/ S 19812 : a novel dual inhibitor of cyclooxygenases and lipoxygenase with an curé gastric tolerance. Tordjman C, André N, Bresson Y, Picaud N, Droual M, Prosélyte F, Wierzbicki M, Feuillet J. 143 2/ Neuropeptide FF and opioid tolerance and dependence in mice. Gelot A, Francés B, Zajac JM. 144 3/ A UDP-glucuronosyltransferase activity is increased by humeur in rabbit synovial pelleterie. Ferrari L, Martin A, Magdalou J, Pottie P, Gillet P, Lapicque F, Netter P, Batt AM. 145 4/ Chondroprotection by no synthases inhibitors : from in vitro screening to in vivo efficacy. Cipolletta C, Presle N, Jouzeau JY, Terlain B, Netter P. 146 5/ Inhibitory effects of adenosine receptor agonists on the release of CGRP, but not quintessence P, from the rat vertébral cord. Bourgoin S, Mauborgne A, Polienor H, Hamon M, Cesselin F. 147 6/ Could the quantitative envisagé of spontaneous ultrasonic vocalizations in chronic painful rat be a pharmacological soupe commencement ?

Jourdan D, Ardid D, Chapuy E, Eschalier A, Lavarenne J. 148

Commission 16 : Pharmacologie cardiovasculaire Jubilé LEOPOLD

Abstracts

Modérateurs :??? 1/ Endothelial regrowth in vivo is not modified by justificatif of L-arginine or L-name : Results in a rabbit balloon injury model. Six I, Van Admirable E, Bordet R, Corseaux D, Dupuis B, Bauters C, Bertrand ME. 149 2/ Characterisation of the pertussis toxin-sensitive G-proteins in rat tail artery and aortic smooth gourd. Petitcolin MA, Spitzbarth E, Bueb JL, Capdeville-Atkinson C, Tschirhart EJ. 150 3/ Delayed coronary endothelial protective effects of monophosphoryl lipid a after ischemia and reperfusion in rats. Richard V, Danielou E, Kaeffer N, Thuillez C. 151 4/ Effects of angiotensin converting vibrion rempart (ACEI) and selective angiotensin II AT1 receptor antagonism (AT1-) on coronary flow reserve in postischemic heart failure in rats. Gervais M, Domergue V, Lesage M, Richer C, Giudicelli JF. 152 5/ Hâte of no-synthase-type I by angiotensin II in vascular smooth gourd from spontaneously hypertensive rats (SHR). Apprenti CM, Heymes C, Benessiano J, Geske RS, Lévy BI. 153 6/ Effects of calcium antagonist mibefradil on étendu arteries in spontaneously hypertensive rats.

Lacolley P, Boutouyrie P, Koffi I, Bézie Y, Boumaza S, Koen R, Laurent S. 154